Citigroup Inc. reiterated their buy rating on shares of Merck KGaA (FRA:MRK) in a report released on Wednesday.

Several other analysts also recently weighed in on the stock. Goldman Sachs Group Inc. set a €99.00 ($106.45) price target on shares of Merck KGaA and gave the company a neutral rating in a research note on Monday, October 17th. Commerzbank AG set a €101.00 ($108.60) price target on shares of Merck KGaA and gave the company a buy rating in a research note on Friday, July 22nd. JPMorgan Chase & Co. reaffirmed a neutral rating on shares of Merck KGaA in a research note on Thursday, July 21st. Bankhaus Lampe set a €112.00 ($120.43) price target on shares of Merck KGaA and gave the company a buy rating in a research note on Tuesday. Finally, equinet AG set a €91.00 ($97.85) price target on shares of Merck KGaA and gave the company a neutral rating in a research note on Friday, October 14th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have given a buy rating to the company. Merck KGaA presently has an average rating of Hold and a consensus price target of €101.91 ($109.58).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) traded down 0.04% during trading on Wednesday, reaching €94.27. The company had a trading volume of 676 shares. The stock has a 50 day moving average of €95.61 and a 200-day moving average of €92.97. Merck KGaA has a 12-month low of €70.87 and a 12-month high of €100.00. The stock has a market capitalization of €40.99 billion and a P/E ratio of 29.50.

Merck KGaA Company Profile

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.